GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panacea Biotec Ltd (BOM:531349) » Definitions » Additional Paid-In Capital

Panacea Biotec (BOM:531349) Additional Paid-In Capital : ₹0 Mil(As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Panacea Biotec Additional Paid-In Capital?


Panacea Biotec's annual additional paid-in capital stayed the same from Mar. 2022 (₹1,942 Mil) to Mar. 2023 (₹1,942 Mil) but then declined from Mar. 2023 (₹1,942 Mil) to Mar. 2024 (₹0 Mil).


Panacea Biotec Additional Paid-In Capital Historical Data

The historical data trend for Panacea Biotec's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panacea Biotec Additional Paid-In Capital Chart

Panacea Biotec Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,941.74 1,941.74 1,941.74 1,941.74 -

Panacea Biotec Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,941.74 - - - -

Panacea Biotec Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Panacea Biotec Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Panacea Biotec's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Panacea Biotec (BOM:531349) Business Description

Traded in Other Exchanges
Address
Mathura Road, B-1 Extn./G-3, Mohan Co-operative Industrial Estate, New Delhi, IND, 110 044
Panacea Biotec Ltd is a Biotechnology company. It is engaged in the business of research, development, manufacturing, and marketing of branded pharmaceutical formulations, vaccines, and biopharmaceuticals. The company's operating segments include Vaccines, and Formulations. It generates maximum revenue from the Vaccines segment. The company product portfolio includes prescription products in niche therapeutic areas such as diabetes and cardiovascular management, oncology, nephrology and transplant management, osteoporosis management, gastro-intestinal care, pain management products, and pediatric immunization. The group has a business presence in India and Outside India.

Panacea Biotec (BOM:531349) Headlines

No Headlines